Celldex Therapeutics Inc.’s recently made public that its SR. VP & CPDO Crowley Elizabeth unloaded Company’s shares for reported $1.05 million on Jun 14 ’24. In the deal valued at $34.87 per share,30,000 shares were sold. As a result of this transaction, Crowley Elizabeth now holds 9,074 shares worth roughly $0.34 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Martin Samuel Bates sold 17,172 shares, generating $608,315 in total proceeds. Upon selling the shares at $35.42, the SVP AND CFO now owns 28,125 shares.
Before that, Young Diane C. sold 45,000 shares. Celldex Therapeutics Inc. shares valued at $1,586,844 were divested by the SVP, CHIEF MEDICAL OFFICER at a price of $35.26 per share. As a result of the transaction, Young Diane C. now holds 2,115 shares, worth roughly $78276.15.
Stifel initiated its Celldex Therapeutics Inc. [CLDX] rating to a Buy in a research note published on June 18, 2024; the price target was $58. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid June with a ‘”an Outperform”‘ rating. TD Cowen began covering CLDX with “an Outperform” recommendation on December 20, 2023. Wells Fargo revised its rating on November 10, 2023. It rated CLDX as “an Equal weight” which previously was an “an Underweight”.
Price Performance Review of CLDX
On Friday, Celldex Therapeutics Inc. [NASDAQ:CLDX] saw its stock fall -1.80% to $37.01. Over the last five days, the stock has gained 4.93%. Celldex Therapeutics Inc. shares have fallen nearly -6.68% since the year began. Nevertheless, the stocks have risen 5.59% over the past one year. While a 52-week high of $53.18 was reached on 03/04/24, a 52-week low of $22.11 was recorded on 06/04/24. SMA at 50 days reached $37.16, while 200 days put it at $35.43. A total of 2.65 million shares were traded, compared to the trading of 0.4 million shares in the previous session.
Levels Of Support And Resistance For CLDX Stock
The 24-hour chart illustrates a support level at 36.15, which if violated will result in even more drops to 35.29. On the upside, there is a resistance level at 37.96. A further resistance level may holdings at 38.91. The Relative Strength Index (RSI) on the 14-day chart is 54.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.15, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 25.74%. Stochastics%K at 81.29% indicates the stock is a selling.
The most recent change occurred on August 22, 2023 when Wells Fargo began covering the stock and recommended ‘”an Underweight”‘ rating along with a $21 price target.
